Cargando…

Use of botulinum toxin for movement disorders

The term movement disorders encompasses all disorders hypokinetic and hyperkinetic, which were previously known as extrapyramidal syndromes. With the definition of movement disorders and their diagnostic criteria and classifications, new studies for therapeutics could be performed. New drugs were la...

Descripción completa

Detalles Bibliográficos
Autores principales: Camargo, Carlos Henrique Ferreira, Teive, Hélio Afonso Ghizoni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586173/
https://www.ncbi.nlm.nih.gov/pubmed/31258617
http://dx.doi.org/10.7573/dic.212586
_version_ 1783428853800108032
author Camargo, Carlos Henrique Ferreira
Teive, Hélio Afonso Ghizoni
author_facet Camargo, Carlos Henrique Ferreira
Teive, Hélio Afonso Ghizoni
author_sort Camargo, Carlos Henrique Ferreira
collection PubMed
description The term movement disorders encompasses all disorders hypokinetic and hyperkinetic, which were previously known as extrapyramidal syndromes. With the definition of movement disorders and their diagnostic criteria and classifications, new studies for therapeutics could be performed. New drugs were launched, functional neurosurgery was developed, and the introduction of botulinum toxin (BoNT) for hyperkinesias was introduced. BoNT is an important therapy for dystonia, tics, myoclonus, and tremors. The aim of this review is to present the new and well-established uses of BoNT for movement disorders.
format Online
Article
Text
id pubmed-6586173
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioExcel Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-65861732019-06-28 Use of botulinum toxin for movement disorders Camargo, Carlos Henrique Ferreira Teive, Hélio Afonso Ghizoni Drugs Context Review The term movement disorders encompasses all disorders hypokinetic and hyperkinetic, which were previously known as extrapyramidal syndromes. With the definition of movement disorders and their diagnostic criteria and classifications, new studies for therapeutics could be performed. New drugs were launched, functional neurosurgery was developed, and the introduction of botulinum toxin (BoNT) for hyperkinesias was introduced. BoNT is an important therapy for dystonia, tics, myoclonus, and tremors. The aim of this review is to present the new and well-established uses of BoNT for movement disorders. BioExcel Publishing Ltd 2019-06-18 /pmc/articles/PMC6586173/ /pubmed/31258617 http://dx.doi.org/10.7573/dic.212586 Text en Copyright © 2019 Camargo CHF, Teive HAG. Published by Drugs in Context under Creative Commons License Deed CC BY NC ND 4.0 which allows anyone to copy, distribute, and transmit the article provided it is properly attributed in the manner specified below. No commercial use without permission.
spellingShingle Review
Camargo, Carlos Henrique Ferreira
Teive, Hélio Afonso Ghizoni
Use of botulinum toxin for movement disorders
title Use of botulinum toxin for movement disorders
title_full Use of botulinum toxin for movement disorders
title_fullStr Use of botulinum toxin for movement disorders
title_full_unstemmed Use of botulinum toxin for movement disorders
title_short Use of botulinum toxin for movement disorders
title_sort use of botulinum toxin for movement disorders
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586173/
https://www.ncbi.nlm.nih.gov/pubmed/31258617
http://dx.doi.org/10.7573/dic.212586
work_keys_str_mv AT camargocarloshenriqueferreira useofbotulinumtoxinformovementdisorders
AT teivehelioafonsoghizoni useofbotulinumtoxinformovementdisorders